LINC01231

Across TCGA pan-cancer cohorts, LINC01231 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01231’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01231 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01231 is over-expressed in tumor, although a few such as BRCA and HNSC show the opposite, repressed pattern.

BRCA and HNSC are the cancer types where LINC01231 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01231 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	−0.038	.027	2	view →
HNSC	All	II,III,IV	−0.035	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC01231–BRCA

Open the BRCA breakdown →